CliffBio
small molecule

CAFFEINE CITRATE

CAFFEINE CITRATE

Loss of exclusivity—loss of exclusivity
CompanyExela Pharma Sciences Llc →See this company's full patent-cliff portfolio

Drug detail

Brand nameCAFFEINE CITRATE
Active ingredientCAFFEINE CITRATE
StrengthEQ 30MG BASE/3ML (EQ 10MG BASE/ML)
Dosage formSOLUTION
RouteORAL
ModalitySmall molecule
FDA approvalSeptember 2006
Marketing statusRX

More from Exela Pharma Sciences Llc

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.